Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Analyst recommendations
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Tourmaline Bio in a report released on ...
Climb Bio, Inc. (NASDAQ:CLYM – Get Free Report) traded down 0.5% during trading on Wednesday . The company traded as low as $1.78 and last traded at $1.87. 260,564 shares changed hands during ...
Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are presently covering the firm, MarketBeat Ratings reports. One analyst ...